1. Home
  2. PCOR vs CORT Comparison

PCOR vs CORT Comparison

Compare PCOR & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Procore Technologies Inc.

PCOR

Procore Technologies Inc.

N/A

Current Price

$75.57

Market Cap

9.6B

Sector

Technology

ML Signal

N/A

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

N/A

Current Price

$72.63

Market Cap

9.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PCOR
CORT
Founded
2003
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
9.7B
IPO Year
2020
2001

Fundamental Metrics

Financial Performance
Metric
PCOR
CORT
Price
$75.57
$72.63
Analyst Decision
Buy
Buy
Analyst Count
25
5
Target Price
$69.86
★ $142.57
AVG Volume (30 Days)
★ 3.1M
1.0M
Earning Date
11-03-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 6.94
N/A
EPS
0.02
★ 1.13
Revenue
★ $1,322,509,000.00
$761,407,000.00
Revenue This Year
$14.75
$52.09
Revenue Next Year
$17.37
$44.73
P/E Ratio
$1,512.00
★ $70.11
Revenue Growth
★ 14.83
12.79
52 Week Low
$38.03
$28.66
52 Week High
$80.41
$126.38

Technical Indicators

Market Signals
Indicator
PCOR
CORT
Relative Strength Index (RSI) 81.52 21.80
Support Level $46.64 $30.24
Resistance Level N/A $122.93
Average True Range (ATR) 2.79 6.22
MACD 1.48 -2.44
Stochastic Oscillator 76.93 2.99

Price Performance

Historical Comparison
PCOR
CORT

About PCOR Procore Technologies Inc.

Procore Technologies Inc is a cloud-based construction management software company. It generates revenue through subscriptions for access to its software products. The company's products include Design Coordination, BIM, Field Productivity, Project Financials, Invoice Management, Portfolio Financials, Capital Planning, Accounting Integrations, and Analytics. The software products are hosted on its cloud-based SaaS construction management platform. Subscriptions are sold for a fixed fee and revenue is recognized ratably over the term of the subscription.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

Share on Social Networks: